Dietary intake of folate, vitamin B2, vitamin B6, vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Japan.
We investigated associations among intake of folate, vitamin B2, vitamin B6, vitamin B12, and polymorphisms of 5,10-methylenetetrahydrofolate reductase (MTHFR) and methionine synthase (MTR) genes and breast cancer risk in a Japanese population. A hospital based, case-control study was conducted in Nagano Prefecture, Japan, in 388 pairs of patients with histologically confirmed invasive breast cancer and age- and area-matched controls selected from medical checkup examinees. Energy-adjusted intakes of folate and other B vitamins were derived from a validated food frequency questionnaire. Genotyping was completed for MTHFR (C677T and A1298T) and MTR (A2756G). Odds ratios and 95% confidence intervals were calculated by the conditional logistical regression model. Median dietary folate intake (microg/day) in the control group was 438.2 (interquartile range: 354.9-542.9). Neither dietary intake of folate, vitamin B2, vitamin B6, or vitamin B12 nor polymorphisms of MTHFR or MTR genes were significantly associated with breast cancer risk. Further, no significant interaction was found among nutrients, polymorphisms, and breast cancer risk. Associations of nutrients with breast cancer risk did not differ by hormone receptors status. We conclude that dietary intake of folate and related B vitamins and genotypes of MTHFR or MTR have no overall association with breast cancer risk in Japanese women.
Ma
Enbo
E
National Cancer Center, Tokyo, Japan.
Iwasaki
Motoki
M
Kobayashi
Minatsu
M
Kasuga
Yoshio
Y
Yokoyama
Shiro
S
Onuma
Hiroshi
H
Nishimura
Hideki
H
Kusama
Ritsu
R
Tsugane
Shoichiro
S
D045103:5,10-Methylenetetrahydrofolate Reductase (FADH2) / Q000235:genetics*; D013766:5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase / Q000235:genetics*; D000328:Adult; D000368:Aged; D015992:Body Mass Index; D001943:Breast Neoplasms / Q000453:epidemiology* / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D016022:Case-Control Studies; D016009:Chi-Square Distribution; D016001:Confidence Intervals; D004032:Diet; D004034:Diet Surveys; D002149:Energy Intake; D005260:Female; D005492:Folic Acid / Q000008:administration & dosage; D006801:Humans; D007564:Japan / Q000453:epidemiology; D016555:Matched-Pair Analysis; D008875:Middle Aged; D009043:Motor Activity; D009361:Neoplasm Invasiveness; D016017:Odds Ratio; D011110:Polymorphism, Genetic; D011960:Receptors, Estrogen / Q000378:metabolism; D011980:Receptors, Progesterone / Q000378:metabolism; D012256:Riboflavin / Q000008:administration & dosage; D012307:Risk Factors; D011795:Surveys and Questionnaires; D014805:Vitamin B 12 / Q000008:administration & dosage; D025101:Vitamin B 6 / Q000008:administration & dosage; D014803:Vitamin B Complex / Q000008:administration & dosage*; D055815:Young Adult
D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D014803:Vitamin B Complex; D025101:Vitamin B 6; D005492:Folic Acid; D045103:5,10-Methylenetetrahydrofolate Reductase (FADH2); D013766:5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; D014805:Vitamin B 12; D012256:Riboflavin